Professional Documents
Culture Documents
Joint Commission
International
Acute Myocardial Infarction
(I-AMI) Measure Set
Version 2.0
Contents
I-AMI Hospital Inpatient Quality Measures ....................................................................................2
I-AMI Data Element/Variable List ..................................................................................................4
I-AMI Initial Eligible Patient Population Criteria..............................................................................5
I-AMI Initial Eligible Patient Population Word Algorithm.................................................................6
Measure Information Forms (including Information Forms, Overviews, Details, References,
Flowcharts, Word Algorithms, and Appendices)
I-AMI-1: Aspirin on Arrival ..................................................................................................7
I-AMI-2: Aspirin Prescribed at Discharge .................................................................................... 15
I-AMI-3: ACEI of ARB for LVSD .........................................................................................22
I-AMI-4: Adult Smoking Counseling ...................................................................................33
I-AMI-5: Beta Blocker Prescribed at Discharge ..................................................................41
I-AMI-9: Inpatient AMI Mortality .........................................................................................48
Appendix A: International Classification of Diseases (ICD) Code Tables ...........................55
Version 2.0
I-AMI-2
I-AMI-3
I-AMI-4
I-AMI-5
I-AMI-9
Inpatient Mortality
Measure Description
Aspirin received within 24 hours of arrival to
the hospital for patients having an Acute
Myocardial Infarction (AMI).
Aspirin prescribed at discharge for patients
who had an Acute Myocardial Infarction
(AMI).
ACEI (Angiotensin Converting Enzyme
Inhibitor) or ARB (Angiotensin Receptor
Blocker) for patients who have LVSD (Left
Ventricular Systolic Dysfunction) after
having an Acute Myocardial Infarction.
Adult Smoking Cessation (cigarette)
advice/counseling given to patients who
had an Acute Myocardial Infarction.
Beta blocker prescribed at discharge for
patients who had an Acute Myocardial
Infarction (AMI).
Acute Myocardial Infarction (AMI) patients
who expire during the hospital stay
Version 2.0
Collected For:
All measures
All measures
All measures
All measures
All measures
All measures
All measures
Collected For:
I-AMI-3
I-AMI-4
I-AMI-4
I-AMI-3
I-AMI-1
I-AMI-2
I-AMI-1
I-AMI-5
I-AMI-1, I-AMI-2, I-AMI-3, I-AMI-4, I-AMI-5,
I-AMI-9
I-AMI-3
I-AMI-3
I-AMI-2
I-AMI-1
I-AMI-5
I-AMI-9
Version 2.0
Admission Date
Birthdate
Discharge Date
Patients admitted to the hospital for inpatient acute care with an ICD Principal Diagnosis
Code or principal diagnosis of Acute Myocardial Infarction (AMI) as defined in Appendix
A, Table 1.1 AND a Patient Age (Admission Date minus Birthdate) greater than or equal
to 18 years of age are included in the I-AMI Initial Patient Population and are
eligible to be sampled.
Version 2.0
1. Start AMI Initial Patient Population logic sub-routine. Process all quarterly discharge
inpatient cases (cases with discharge dates in the specific data collection time period)
that have successfully reached the point in the Data Processing Flow: Do not process
cases that have been rejected before this point in the Data Processing Flow.
2. Check ICD Principal Diagnosis Code
a. If the ICD Principal Diagnosis Code is not on Table 1.1, the patient is not in the AMI
Initial Patient Population and is not eligible to be sampled for the AMI measure set.
Set the Initial Patient Population to equal reject case. Return to Data Processing
Flow.
b. If the ICD Principal Diagnosis Code is on Table 1.1, continue processing and
proceed to Patient Age calculation.
3. Calculate Patient Age. Patient Age, in years, is equal to the Admission Date minus the
Birthdate. Use the month and day portion of Admission Date and Birthdate to yield the
most accurate age.
4. Check Patient Age
a. If the Patient Age is less than 18 years, the patient is not in the I-AMI Initial Patient
Population and is not eligible to be sampled for the I-AMI measure set. Set the Initial
Patient Population to equal reject case. Return to Data Processing Flow.
b. If the Patient Age is greater than or equal to 18 years, continue processing and
proceed to each measures Clinical Data Processing Flow.
Version 2.0
Version 2.0
Measure-Related
Domains of
Performance
Measure-Related
Measure- MeasureQuality Improvement and
Related
Topic
Patient Safety (QPS)
Clinical
Related
Standards
Care
I-Patient
QPS.3 through QPS.3.3 Intent Program
Safety
Statement Clinical Areas Certification Goals
Appropriateness
QPS.3.1
Availability
1. patient assessments
Continuity
Effectiveness
AMI
Goal 1
medication use
Timeliness
Version 2.0
I-AMI-1
Measure Details
Reasons and Implications: The benefits of aspirin therapy on mortality are
comparable to fibrinolytic therapy. The combination of aspirin and fibrinolytics provides
additive benefit for patients with ST-elevation myocardial infarction and aspirin is also
effective in patients with non-ST-elevation Myocardial Infarction. Clinical guidelines
strongly recommend aspirin for patients hospitalized with AMI.
Data Collection:
Retrospective data sources for the required data elements include administrative data
and medical records.
Numerator: AMI patients who received aspirin within 24 hours before or after hospital
arrival
Data Elements:
Aspirin Received Within 24 Hours Before or After Hospital Arrival
Inclusions to the numerator population: Not Applicable
Exclusions from the numerator population: None
Denominator: AMI patients who are >= 18 years
Data Elements:
Arrival Date
Birthdate
Discharge Disposition
ICD Principal Diagnosis Code
Reason for No Aspirin on Arrival
Inclusions to the denominator population: Patients with ICD Principal Diagnosis
Code for AMI as defined in Appendix A, Table 1.1.
Exclusions from the denominator population:
Patients less than 18 years of age
Patients who left against medical advice
Patients who expired on day of or day after arrival
Use Ctrl + Home keys to go to the title page
Specification Manual for the Joint Commission International Library of Measures
Version 2.0, effective for January 2013 discharges (1st Quarter 2013)
2011 Joint Commission International
Version 2.0
10
Version 2.0
I-AMI-1
References
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al.
ACC/AHA 2007 guidelines for the management of patients with unstable
angina/nonST-elevation myocardial infarction: a report of the American College
of Cardiology/American Heart Association Task Force on Practice Guidelines
(Writing Committee to Revise the 2002 Guidelines for the Management of Patients
With Unstable Angina/NonST-Elevation Myocardial Infarction): developed in
collaboration with the American College of Emergency Physicians, American
College of Physicians, Society for Academic Emergency Medicine, Society for
Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
J Am Coll Cardiol. 2007;50:e1157.
Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al.
ACC/AHA guidelines for the management of patients with ST-elevation myocardial
infarction: a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (Committee to Revise the 1999
Guidelines for the Management of Patients With Acute Myocardial Infarction).
2004.
Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, et
al. ACC/AHA 2008 performance measures for adults with ST-elevation and non
ST-elevation myocardial infarction: a report of the American College of
Cardiology/American Heart Association Task Force on Performance Measures
(Writing Committee to Develop Performance Measures for ST-Elevation and Non
ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2008;52:2046 99.
Randomized trial of intravenous streptokinase, oral aspirin, both or neither among
17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second
International Study of Infarct Survival) Collaborative Group. Lancet. 1988 Aug
13;2(8607):349w-60.
Risk of myocardial infarction and death during treatment with low dose aspirin and
intravenous heparin in men with unstable coronary artery disease. The RISC
Group. Lancet. 1990;336(8719):827-830.
Theroux P, Ouimet H, McCans J et al. Aspirin, heparin, or both to treat acute
unstable angina. N Engl J Med. 1988;319(17):1105-1111.
11
Version 2.0
I-AMI-1
Aspirin on Arrival
START
ICD Principal
Diagnosis Code
for Acute Myocardial
Infarction(AMI)
NO
< 18 years
YES
Patient Age
= > 18years
Arrival Date
UTD
2, 3, or 4a
Valid Date
Discharge
Disposition
1, 4b, 5, or 6
Aspirin
Received Within 24
Hours Before or After
Hospital Arrival
YES
YES
NO
Reason for
No Aspirin on
Arrival
NO
STOP
12
Version 2.0
13
Version 2.0
Measure Calculation:
After the case data abstraction and data flow is completed, circle the assigned
Measure Category Assignment (MCA) Letter for each measure as guided by the
allowable answer value text:
I-AMI-1
B-Excluded
D-Not met
E-Met/Passed
measure*
measure**
When calculating measure rate for all abstracted cases in the discharge month:
Numerator cases = E
Denominator cases = D plus E
Divide the numerator counts by the denominator counts and X 100 = percentage
rate of measure compliance with recommended standard of care
Glossary Terms:
*Not Met Measure refers to a medical record which does not contain all of the criteria
required to be part of the measures numerator population.
**Met Measure refers to a medical record which contains all of the criteria required to
be part of the measures numerator population.
14